Contribution: Industrial Research Assistance Program – Contributions to Firms
Incisive Genetics Inc.
$375,000.00
Neurological, ocular and bone-marrow gene targeting therapy applications
FY 2022-23 · 2022-04-01
Summary
The project will involve the development of expanded Huntington's Disease gene therapy strategies, addition of retinal and bone marrow targeting capabilities, and demonstration of the delivery of alternate gene editing cargos.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
758555288
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2022-04-01 | 2022-23 | $300,000.00 |
| 1 | 2022-04-01 | 2022-23 | $375,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 75,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 75 000 dollars.
Agreement End Date
2023-03-24
Agreement Number
988559
Agreement Start Date
2022-04-01
Agreement Title
Neurological, ocular and bone-marrow gene targeting therapy applications
Agreement Title (French)
Applications de thérapie génique neurologique, oculaire et de la moelle osseuse
Agreement Type
Contribution
Agreement Value
$375,000.00
Amendment Date
2022-08-25
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The project will involve the development of expanded Huntington's Disease gene therapy strategies, addition of retinal and bone marrow targeting capabilities, and demonstration of the delivery of alternate gene editing cargos.
Description (French)
Le projet comprendra la création de stratégies élargies de thérapie génique de la maladie de Huntington, l'ajout de capacités de ciblage de la rétine et de la moelle osseuse, et la démonstration de l'administration de différentes cargaisons pour l'édition génique.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Quadra
Federal Riding (French)
Vancouver Quadra
Federal Riding Number
59039
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
758555288
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Incisive Genetics Inc.
Recipient Postal Code
V6S 1Z3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2022-2023-Q1-988559
